FDA Approved: DIFLUCAN — Supplemental Application (Roerig)

View source ↗

Summary

The FDA approved a supplemental application for Diflucan (fluconazole) submitted by Roerig.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Candidiasis
• Cryptococcal Meningitis
• Esophageal Candidiasis
• Invasive Candidiasis
• Vulvovaginal Candidiasis

Drugs mentioned

• Diflucan (Fluconazole)

Snippet

SUPPL AP for DIFLUCAN (FLUCONAZOLE)